Hi George,
Great research there, thank you & yes I see what you mean regarding Omics & Luben with Baxter, but Omics still listed on LinkedIn as current, but website is down?
I wonder what is going on there? I think we need some answers on this.
It’s possible that PromarkerD may be licenced under a different brand name by Patia?
Regarding Atturos (based in Ireland), they are making their mass spectrometry available for potential licence partners in EU, & there lab is set up for PromarkerD. Invokana is still waiting on EU approval by the EMA for CKD/CVD indication, although this has been granted fast tracking for approval.
@Bella, yes that part of the presentation has not been updated either regarding Invokana having FDA approval for CKD/CVD.
The costing of the test as George picked up was interesting. They are in discussions with “potential global partners”. We really didn’t receive any new information here in this update, so it would be great to know “what’s cooking”?
Hopefully not long now.
Ann: PIQ market update, page-14
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.005(0.49%) |
Mkt cap ! $134.2M | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.06 | $1.00 | $134.2K | 131.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3987 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 4762 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |